NHK-Fintiv: reaching the tipping point?
US Court of Appeals for the Federal Circuit in Washington, DC - Bill Perry / Shutterstock.com
Leading tech and life sciences companies including Verizon, Comcast and Mylan Pharmaceuticals have asked the US Supreme Court to order the US Court of Appeals for the Federal Circuit to reconsider inter partes review (IPR) petitions that have been denied due to the NHK-Fintiv rule.
The rest of this article is locked for subscribers only. Please login to continue reading.
If you don't have a login, you will need to purchase a subscription to gain access to this article, including all our online content. Please use this link and follow the steps.
To request a FREE 2-week trial subscription, use the same link but select the 'trial' option in the dropdown box. NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription to us that we can add you to for FREE, please email Atif Choudhury at firstname.lastname@example.org
NHK-Fintiv, Apple, Verizon, Comcast, Mylan Pharmaceuticals, inter partes review, US Supreme Court, US Court of Appeals for the Federal Circuit